| Mary T Champion, MD | |
|
7400 State Line Rd Ste 100, Prairie Village, KS 66208-3447 | |
| (913) 588-6600 | |
| (913) 588-6655 |
| Full Name | Mary T Champion |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 13 Years |
| Location | 7400 State Line Rd Ste 100, Prairie Village, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760779722 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kansas Hospital | Kansas city, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kansas University Physicians, Inc. | 8921911587 | 1456 |
News Archive
The U.S. Food and Drug Administration approved Afinitor (everolimus), the first drug approved specifically to treat non-cancerous kidney tumors (renal angiomyolipomas) not requiring immediate surgery in patients with tuberous sclerosis complex.
November is Lung Cancer Awareness Month, highlighting the number one cause of cancer-related death in North America. While prognosis for the most common form, adenocarcinoma, has remained poor, new research has shown a link between the absence of a specific protein and improved patient outcomes.
The risk of kidney failure caused by multiple myeloma appears to be declining, and survival is lengthening for patients who do develop kidney failure due to this cancer.
Researchers from Boston University's Slone Epidemiology Center have found that exposure to pseudoephedrine, a decongestant found in many cough-and-cold and allergy medications, has been common among U.S. children, especially those under the age of two years who are at the highest risk for toxicity and for whom safe dosing recommendations are lacking.
› Verified 5 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
The U.S. Food and Drug Administration approved Afinitor (everolimus), the first drug approved specifically to treat non-cancerous kidney tumors (renal angiomyolipomas) not requiring immediate surgery in patients with tuberous sclerosis complex.
November is Lung Cancer Awareness Month, highlighting the number one cause of cancer-related death in North America. While prognosis for the most common form, adenocarcinoma, has remained poor, new research has shown a link between the absence of a specific protein and improved patient outcomes.
The risk of kidney failure caused by multiple myeloma appears to be declining, and survival is lengthening for patients who do develop kidney failure due to this cancer.
Researchers from Boston University's Slone Epidemiology Center have found that exposure to pseudoephedrine, a decongestant found in many cough-and-cold and allergy medications, has been common among U.S. children, especially those under the age of two years who are at the highest risk for toxicity and for whom safe dosing recommendations are lacking.
› Verified 5 days ago
| Entity Name | The Childrens Mercy Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851437719 PECOS PAC ID: 2466366026 Enrollment ID: O20050721001065 |
News Archive
The U.S. Food and Drug Administration approved Afinitor (everolimus), the first drug approved specifically to treat non-cancerous kidney tumors (renal angiomyolipomas) not requiring immediate surgery in patients with tuberous sclerosis complex.
November is Lung Cancer Awareness Month, highlighting the number one cause of cancer-related death in North America. While prognosis for the most common form, adenocarcinoma, has remained poor, new research has shown a link between the absence of a specific protein and improved patient outcomes.
The risk of kidney failure caused by multiple myeloma appears to be declining, and survival is lengthening for patients who do develop kidney failure due to this cancer.
Researchers from Boston University's Slone Epidemiology Center have found that exposure to pseudoephedrine, a decongestant found in many cough-and-cold and allergy medications, has been common among U.S. children, especially those under the age of two years who are at the highest risk for toxicity and for whom safe dosing recommendations are lacking.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary T Champion, MD 7400 State Line Rd Ste 100, Prairie Village, KS 66208-3447 Ph: (913) 588-6600 | Mary T Champion, MD 7400 State Line Rd Ste 100, Prairie Village, KS 66208-3447 Ph: (913) 588-6600 |
News Archive
The U.S. Food and Drug Administration approved Afinitor (everolimus), the first drug approved specifically to treat non-cancerous kidney tumors (renal angiomyolipomas) not requiring immediate surgery in patients with tuberous sclerosis complex.
November is Lung Cancer Awareness Month, highlighting the number one cause of cancer-related death in North America. While prognosis for the most common form, adenocarcinoma, has remained poor, new research has shown a link between the absence of a specific protein and improved patient outcomes.
The risk of kidney failure caused by multiple myeloma appears to be declining, and survival is lengthening for patients who do develop kidney failure due to this cancer.
Researchers from Boston University's Slone Epidemiology Center have found that exposure to pseudoephedrine, a decongestant found in many cough-and-cold and allergy medications, has been common among U.S. children, especially those under the age of two years who are at the highest risk for toxicity and for whom safe dosing recommendations are lacking.
› Verified 5 days ago
Miles Greenwald, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7400 State Line Rd, Prairie Village, KS 66208 Phone: 913-588-6600 | |
Stephen Longshore Ambrose, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7400 State Line Rd, Prairie Village, KS 66208 Phone: 913-588-6600 Fax: 913-588-6655 | |
Dr. Raymond E Kandt Jr., M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 4950 W 88th St, Prairie Village, KS 66207 Phone: 913-381-4544 | |
Jason Aaron Sokol, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7400 State Line Rd, Suite 100, Prairie Village, KS 66208 Phone: 913-588-6605 Fax: 913-588-0888 | |
Andrew Kalina, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 7400 State Line Rd, Prairie Village, KS 66208 Phone: 913-588-6660 Fax: 913-588-0888 | |
Dr. Miranda Nabil Bishara, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7400 State Line Rd, Suite 100, Prairie Village, KS 66208 Phone: 913-588-6600 Fax: 913-588-6655 | |
Steven R Unterman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3830 W 75th St, Prairie Village, KS 66208 Phone: 913-384-1441 Fax: 913-384-3437 |